Please provide your email address to receive an email when new articles are posted on . CHICAGO — Results showed several surgical and patient factors were significantly associated with conversion from ...

Phase II study of trastuzumab with irinotecan in HER2-positive metastatic or advanced gastric cancer patients previously treated with trastuzumab and failed: HGCSG 1201/OGSG1205. This is an ASCO ...

Can primary tumor localization predict the which patient will have benefit from addition of taxanes to platin-5-FU based regimens in metastatic gastric cancer. Multi center retrospective analysis from ...

Conversion surgery after active surveillance for low-risk papillary thyroid carcinoma (PTC) led to no clinically meaningful differences in outcomes as compared with immediate surgery, according to a ...

Conversion surgery is becoming a viable option for patients with metastatic gastric cancer who respond well to induction chemotherapy, said gastric cancer specialist Jimmy So at the Institute of ...